MC Gillies, FM Islam, M Zhu, J Larsson, TY … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: One IVTA injection was required in 6 (18%) eyes, 2 in 8 (24%) eyes, 3
in 13 (39%) eyes and 4–5 in 6 (18%) eyes. VA improved in all patients, but
neither the final improvement in VA nor the absolute improvement in CMT ... Cited by 11 - Related articles - BL Direct - All 4 versions
J Larsson, A Kifley, M Zhu, JJ Wang, P … - Acta Ophthalmol, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 4 versions
- ►nih.gov CKM Chan, S Mohamed, MP Shanmugam, CW … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Results: BCVA, CFT, intraocular pressure (IOP), and cataract scores were not
significantly different before initial and repeat injections (given at 32.5 (SD
3.5) weeks after the first injection). Transient improvements of BCVA and ... Cited by 24 - Related articles - BL Direct - All 8 versions
A Ramezani, H Tabatabaie, H Ahmadieh - Korean Journal of Ophthalmology: KJO, 2007 - pubmedcentral.nih.gov In a prospective interventional case series, twenty five eyes with refractory
DME which had been allocated to the sham group of a previous clinical trial
underwent new examination and optical coherence tomography about 9 months ... Cited by 4 - Related articles - BL Direct - All 10 versions
DSC Lam, CKM Chan, S Mohamed, TYY Lai, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: After ivTA injection, improvements of BCVA and CFT occurred in all
groups. The mean BCVA improvement at 6 months was significantly higher for the 8
mg group compared with the 4 mg group, with 9.9 and 3.1 improvement in ... Cited by 29 - Related articles - BL Direct - All 5 versions
P Pearson, B Levy… - Investigative Ophtalmology and Visual Science, 2005 - ARVO Commercial Relationships: P. Pearson, Control Delivery Systems Inc. P; Bausch &
Lomb Inc. C; B. Levy, Bausch & Lomb Inc. E. ... Purpose: A multi–center,
randomized, controlled clinical trial was conducted to determine the safety ... Cited by 6 - Related articles
T Kube, S Schmidt, F Toonen, B Kirchhof, S … - Ophthalmologica, 2005 - content.karger.com Background: In patients with diabetic maculopathy, evaluation of visual acuity
alone may not represent central retinal function sufficiently. Despite good
visual acuity, patients may suffer from visual disturbances like waviness, ... Cited by 10 - Related articles - All 5 versions
J Baath, AL Ells, A Crichton, A Kherani, RG … - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertonline.com Background: There is currently a widespread use of intravitreal triamcinolone
acetonide (IVTA) for age-related macular degeneration, diabetic macular edema,
cystoid macular edema secondary to retinal vein occlusions, and uveitis. ... Cited by 11 - Related articles - BL Direct - All 4 versions
A Özkiris - Ocular immunology and inflammation, 2006 - informahealthcare.com Purpose: To assess the efficacy and complications of intravitreal triamcinolone
acetonide (IVTA) injection in the treatment of posterior uveitis and to compare
the outcomes with patients who had received systemic corticosteroids. ... Cited by 10 - Related articles - BL Direct - All 6 versions
T Otani, S Kishi - Ophthalmology, 2007 - Elsevier To report the relationship between the findings of third-generation optical
coherence tomography (OCT) and fluorescein angiography (FA) in eyes with
diabetic macular edema (DME). ... We compared findings from late-phase FA ... Cited by 11 - Related articles - All 15 versions
